首页 > 市场调查报告书 > 製药

癌症

2030 年亚太地区神经胶质瘤治疗市场预测 - 区域分析 - 按疾病、治疗类型、等级和最终用户

市场调查报告书

商品编码

1452585

2030 年亚太地区神经胶质瘤治疗市场预测 - 区域分析 - 按疾病、治疗类型、等级和最终用户

Asia Pacific Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease, Treatment Type, Grade, and End User

出版日期: 2024年01月15日 | 出版商:

The Insight Partners | 英文 97 Pages | 订单完成后即时交付

价格

简介目录图表

亚太地区胶质瘤治疗市场预计将从2022年的7.5497亿美元成长到2030年的15.3888亿美元。预计2022年至2030年CAGR为9.3%。

新兴经济体增加的机会推动亚太地区神经胶质瘤治疗市场

巴西、俄罗斯、印度、中国和南非（金砖国家）是世界上成长最快的经济体之一。这些国家以及其他发展中经济体的医疗保健产业预计将在未来几年迅速扩张。预期成长归因于客户需求的变化、医疗保健服务意识的提高以及人口老化的持续增长。随着医疗保健产业的蓬勃发展，全球脑癌诊断市场可能在未来几年显着成长。此外，政府在医疗保健设施上的支出增加和消费者购买力有助于发展中国家医疗保健产业的成长。

由于持续的临床研究、集中的医疗机构、高素质和积极性高的劳动力以及优良的临床试验设施，亚洲国家的科学能力正在不断增长。此外，亚太地区许多国家拥有庞大且多样化的患者库，约 60% 的全球人口居住在该地区。亚太地区遵循美国和欧盟监管机构制定的治疗指南来治疗疾病，这为大量、快速招募患者提供了坚实的前景。因此，亚太地区发展中国家不断成长的医疗保健产业为亚太地区神经胶质瘤治疗市场参与者扩大业务创造了更好的机会。

亚太地区神经胶质瘤治疗市场概述

亚太地区的胶质瘤治疗市场预计在预测期内将以最快的CAGR成长；中国、印度和日本是该地区市场成长的三个主要贡献者。该市场主要受到各国政府和私营部门投资增加的推动。亚洲国家和西方国家在治疗开发方面合作的加强、对脑癌治疗的需求不断增加以及脑肿瘤患病率的上升是可能推动该地区亚太神经胶质瘤治疗市场的几个关键因素在预测期内。

中国是人口大国，医疗卫生基础设施发达。沿海地区和农村地区社会经济发展程度有差异。与西部农村地区相比，沿海地区的医疗资源相对发达且容易取得。与其他已开发国家和发展中国家一样，日本也致力于加强其医疗保健系统并为其公民提供更好的医疗服务。政府正在透过各种计划和机构鼓励基因组测试的进步。此外，老年人口的增加和脑肿瘤发病率的飙升预计将有助于亚太地区神经胶质瘤治疗市场的发展。

亚太地区胶质瘤治疗市场收入及 2030 年预测（百万美元）

亚太地区神经胶质瘤治疗市场区隔

亚太地区神经胶质瘤治疗市场按疾病、治疗类型、等级、最终用户和国家进行细分。

根据疾病，亚太地区神经胶质瘤治疗市场分为星状细胞瘤、少突星状细胞瘤和少突胶质细胞瘤。 2022 年，星状细胞瘤细分市场占据亚太地区神经胶质瘤治疗市场的最大份额。

依治疗类型，亚太地区神经胶质瘤治疗市场分为手术、化疗、放射治疗等。 2022年，手术细分市场在亚太地区神经胶质瘤治疗市场中占最大份额。

根据级别，亚太地区神经胶质瘤治疗市场分为低级别和高级别。 2022 年，高层级细分市场在亚太地区神经胶质瘤治疗市场中占有更大份额。

根据最终用户，亚太地区神经胶质瘤治疗市场分为医院和诊所以及门诊手术中心。 2022年，医院和诊所细分市场在亚太地区神经胶质瘤治疗市场中占有更大份额。

依国家/地区划分，亚太地区神经胶质瘤治疗市场分为中国、日本、印度、韩国、澳洲和亚太地区其他地区。 2022年，中国将主导亚太地区神经胶质瘤治疗市场。

Amgen Inc、Amneal Pharmaceuticals Inc、Biocon Ltd、F. Hoffmann-La Roche Ltd、Merck & Co Inc、Pfizer Inc、Sun Pharmaceutical Industries Ltd 和 Teva Pharmaceutical Industries Ltd 是亚太神经胶质瘤治疗市场上的一些领先公司。

Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world. The healthcare sectors in these countries, as well as other developing economies, are projected to expand rapidly in the coming years. The expected growth is ascribed to changes in customer demand, an increase in awareness about healthcare services, and a continuous rise in the aging population. The global brain cancer diagnostics market is likely to grow significantly in the coming years with the proliferation of the healthcare sector. Further, increased government spending on healthcare facilities and consumer purchasing power contribute to the growth of the healthcare sector in developing countries.

Asian countries are witnessing continuous growth in their scientific capabilities, owing to the ongoing clinical research studies, centralized healthcare institutions, well-qualified and highly motivated workforces, and excellent clinical trial facilities. Further, many countries in Asia Pacific have a large and diverse patient pool, with ~60% of the global population residing in the region. Treatment guidelines prepared by regulatory bodies in the US and EU are followed in Asia Pacific for treating diseases, which offers solid prospects for significant and rapid patient recruitment. Thus, the growing healthcare sector in developing countries in Asia Pacific creates better opportunities for the Asia Pacific glioma treatment market players to expand their business.

Asia Pacific Glioma Treatment Market Overview

The Asia Pacific glioma treatment market in Asia Pacific is expected to grow at the fastest CAGR during the forecast period; China, India, and Japan are three major contributors to the market growth in this region. The market is mainly driven by increasing investments by the government and private sectors of the respective countries. A rise in collaborations among Asian countries and Western countries for the development of treatment, increasing demand for brain cancer treatments, and rising prevalence of brain tumors are a few of the key factors that are likely to drive the Asia Pacific glioma treatment market in this region during the forecast period.

China is a country with a vast population and has flourished healthcare infrastructure. The extent of social and economic development differs between the coastal area and rural areas. In the coastal regions, healthcare resources are relatively well developed and readily available compared to the rural areas in the west. Like any other developed and developing country, Japan also focuses on strengthening its healthcare system and providing better access to health systems to its citizens. The government is encouraging advancements in genomic testing through various programs and institutes. Moreover, the increasing geriatric population and the surging prevalence of brain tumors are expected to contribute to the development of the Asia Pacific glioma treatment market.

Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Glioma Treatment Market Segmentation

The Asia Pacific glioma treatment market is segmented into disease, treatment type, grade, end user, and country.

Based on disease, the Asia Pacific glioma treatment market is segmented into astrocytoma, oligoastrocytoma, and oligodendroglioma. The astrocytoma segment held the largest share of the Asia Pacific glioma treatment market in 2022.

Based on treatment type, the Asia Pacific glioma treatment market is segmented into surgery, chemotherapy, radiation therapy, and others. The surgery segment held the largest share of the Asia Pacific glioma treatment market in 2022.

Based on grade, the Asia Pacific glioma treatment market is segmented into low grade and high grade. The high grade segment held a larger share of the Asia Pacific glioma treatment market in 2022.

Based on end user, the Asia Pacific glioma treatment market is segmented into hospital & clinics and ambulatory surgical center. The hospital & clinics segment held a larger share of the Asia Pacific glioma treatment market in 2022.

Based on country, the Asia Pacific glioma treatment market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific glioma treatment market in 2022.

Amgen Inc, Amneal Pharmaceuticals Inc, Biocon Ltd, F. Hoffmann-La Roche Ltd, Merck & Co Inc, Pfizer Inc, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd are some of the leading companies operating in the Asia Pacific glioma treatment market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Glioma Treatment Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Government Funding for Glioma Treatment
- 4.1.2 Increase in Prevalence of High-Grade Glioma
4.2 Key Market Restraints
- 4.2.1 High Cost of Diagnosis
4.3 Key Market Opportunities
- 4.3.1 Advancements in Healthcare Sector in Emerging Economies
4.4 Future Trends
- 4.4.1 Surge in Drug Approvals for Glioma Treatment
4.5 Impact Analysis:

5. Glioma Treatment Market - Asia Pacific Market Analysis

5.1 Asia Pacific Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease

6.1 Overview
6.2 Asia Pacific Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
6.3 Astrocytoma
- 6.3.1 Overview
- 6.3.2 Astrocytoma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Oligoastrocytoma
- 6.4.1 Overview
- 6.4.2 Oligoastrocytoma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Oligodendroglioma
- 6.5.1 Overview
- 6.5.2 Oligodendroglioma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type

7.1 Overview
7.2 Asia Pacific Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Surgery
- 7.3.1 Overview
- 7.3.2 Surgery: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Chemotherapy
- 7.4.1 Overview
- 7.4.2 Chemotherapy: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Radiation Therapy
- 7.5.1 Overview
- 7.5.2 Radiation Therapy: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade

8.1 Overview
8.2 Asia Pacific Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
8.3 Low Grade
- 8.3.1 Overview
- 8.3.2 Low Grade: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Grade I: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.2 Grade II: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 High Grade
- 8.4.1 Overview
- 8.4.2 High Grade: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.1 Grade III: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.2 Grade IV: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Asia Pacific Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospital & Clinics
- 9.3.1 Overview
- 9.3.2 Hospital & Clinics: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Glioma Treatment Market - Country Analysis

10.1 Overview
- 10.1.1 Asia Pacific Glioma Treatment Market, by Country
  - 10.1.1.1 China
    - 10.1.1.1.1 China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.1.2 China: Asia Pacific Glioma Treatment Market, by Disease
    - 10.1.1.1.3 China: Asia Pacific Glioma Treatment Market, by Treatment Type
    - 10.1.1.1.4 China: Asia Pacific Glioma Treatment Market, by Grade
    - 10.1.1.1.4.1 China: Asia Pacific Glioma Treatment Market, by Low Grade
    - 10.1.1.1.4.2 China: Asia Pacific Glioma Treatment Market, by High Grade
    - 10.1.1.1.5 China: Asia Pacific Glioma Treatment Market, by End User
  - 10.1.1.2 Japan
    - 10.1.1.2.1 Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.2.2 Japan: Asia Pacific Glioma Treatment Market, by Disease
    - 10.1.1.2.3 Japan: Asia Pacific Glioma Treatment Market, by Treatment Type
    - 10.1.1.2.4 Japan: Asia Pacific Glioma Treatment Market, by Grade
    - 10.1.1.2.4.1 Japan: Asia Pacific Glioma Treatment Market, by Low Grade
    - 10.1.1.2.4.2 Japan: Asia Pacific Glioma Treatment Market, by High Grade
    - 10.1.1.2.5 Japan: Asia Pacific Glioma Treatment Market, by End User
  - 10.1.1.3 India
    - 10.1.1.3.1 India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.3.2 India: Asia Pacific Glioma Treatment Market, by Disease
    - 10.1.1.3.3 India: Asia Pacific Glioma Treatment Market, by Treatment Type
    - 10.1.1.3.4 India: Asia Pacific Glioma Treatment Market, by Grade
    - 10.1.1.3.4.1 India: Asia Pacific Glioma Treatment Market, by Low Grade
    - 10.1.1.3.4.2 India: Asia Pacific Glioma Treatment Market, by High Grade
    - 10.1.1.3.5 India: Asia Pacific Glioma Treatment Market, by End User
  - 10.1.1.4 South Korea
    - 10.1.1.4.1 South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.4.2 South Korea: Asia Pacific Glioma Treatment Market, by Disease
    - 10.1.1.4.3 South Korea: Asia Pacific Glioma Treatment Market, by Treatment Type
    - 10.1.1.4.4 South Korea: Asia Pacific Glioma Treatment Market, by Grade
    - 10.1.1.4.4.1 South Korea: Asia Pacific Glioma Treatment Market, by Low Grade
    - 10.1.1.4.4.2 South Korea: Asia Pacific Glioma Treatment Market, by High Grade
    - 10.1.1.4.5 South Korea: Asia Pacific Glioma Treatment Market, by End User
  - 10.1.1.5 Australia
    - 10.1.1.5.1 Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.5.2 Australia: Asia Pacific Glioma Treatment Market, by Disease
    - 10.1.1.5.3 Australia: Asia Pacific Glioma Treatment Market, by Treatment Type
    - 10.1.1.5.4 Australia: Asia Pacific Glioma Treatment Market, by Grade
    - 10.1.1.5.4.1 Australia: Asia Pacific Glioma Treatment Market, by Low Grade
    - 10.1.1.5.4.2 Australia: Asia Pacific Glioma Treatment Market, by High Grade
    - 10.1.1.5.5 Australia: Asia Pacific Glioma Treatment Market, by End User
  - 10.1.1.6 Rest of Asia Pacific
    - 10.1.1.6.1 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.6.2 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by Disease
    - 10.1.1.6.3 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by Treatment Type
    - 10.1.1.6.4 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by Grade
    - 10.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by Low Grade
    - 10.1.1.6.4.2 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by High Grade
    - 10.1.1.6.5 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by End User

11. Asia Pacific Glioma Treatment Market Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Merck & Co Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sun Pharmaceutical Industries Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Amgen Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Pfizer Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Amneal Pharmaceuticals Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Biocon Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Asia Pacific Glioma Treatment Market Segmentation
Table 2. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 3. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 4. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 5. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 6. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 7. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 8. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 9. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 10. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 11. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 12. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 13. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 14. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 15. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 16. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 17. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 18. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 19. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 20. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 21. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 22. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 23. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 24. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - High Grade
Table 25. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 26. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 27. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 28. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 29. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 30. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 31. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 32. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 33. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 34. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 35. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 36. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 37. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 38. Organic Developments Done By Companies
Table 39. Inorganic Developments Done By Companies
Table 40. Glossary of Terms, Asia Pacific glioma treatment market

List Of Figures

Figure 1. Asia Pacific Glioma Treatment Market Segmentation, By Country
Figure 2. Asia Pacific Glioma Treatment Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Asia Pacific Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
Figure 6. Astrocytoma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Oligoastrocytoma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Oligodendroglioma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 10. Surgery: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chemotherapy: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Radiation Therapy: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Asia Pacific Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
Figure 15. Low Grade: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Grade I: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Grade II: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. High Grade: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Grade III: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Grade IV: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Asia Pacific Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
Figure 22. Hospital & Clinics: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Ambulatory Surgical Centers: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Asia Pacific Glioma Treatment Market, By Geography, 2022 ($Mn)
Figure 25. Asia Pacific Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 26. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Growth Strategies Done by the Companies in the Market, (%)